Differentiating Inflammatory Pathways in EGPA and SEA
Study reveals EGPA driven by interferon-mediated inflammation distinct from severe eosinophilic asthma, identifying immune cell signatures and IGF1 pathways as potential therapeutic targets for patients.
Differentiating Inflammatory Pathways in EGPA and SEA
Study reveals EGPA driven by interferon-mediated inflammation distinct from severe eosinophilic asthma, identifying immune cell signatures and IGF1 pathways as potential therapeutic targets for patients.